To include your compound in the COVID-19 Resource Center, submit it here.

BMS's largest institutional shareholder opposes Celgene takeout

Wellington Management said it is against Bristol-Myers Squibb Co. (NYSE:BMY) acquiring Celgene Corp. (NASDAQ:CELG)

Read the full 140 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE